13G Filing: Sabby Capital and Ritter Pharmaceuticals Inc (RTTR)

Page 3 of 7 – SEC Filing

[_]11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)9.9412.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

OO
CUSIP No.
7678361091.
NAME OF REPORTING PERSONSHal Mintz2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a) [_]

(b) [X]

3.
SEC USE ONLY4.
CITIZENSHIP OR PLACE OF ORGANIZATIONUSANUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

5.
SOLE VOTING POWER06.
SHARED VOTING POWER 4,900,0007.
SOLE DISPOSITIVE POWER08.
SHARED DISPOSITIVE POWER 4,900,0009.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,900,00010.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES (SEE INSTRUCTIONS)

[_]11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)